Benjamin M Wu


Affiliation: University of California
Country: USA


  1. Kwak J, Zhang Y, Park J, Chen E, Shen J, Chawan C, et al. Pharmacokinetics and osteogenic potential of PEGylated NELL-1 in vivo after systemic administration. Biomaterials. 2015;57:73-83 pubmed publisher
    ..Our findings suggest that the PEGylation technique presents a viable and promising approach to further develop NELL-1 into an effective systemic therapeutic for the treatment of osteoporosis. ..
  2. Linsley C, Quach V, Agrawal G, Hartnett E, Wu B. Visible light and near-infrared-responsive chromophores for drug delivery-on-demand applications. Drug Deliv Transl Res. 2015;5:611-24 pubmed publisher
    ..These findings have the potential to translate light-actuated drug delivery-on-demand systems from the bench to clinical applications that require explicit control over the presentation of biologically active molecules. ..
  3. Zhang Y, Dong R, Park Y, Bohner M, Zhang X, Ting K, et al. Controlled release of NELL-1 protein from chitosan/hydroxyapatite-modified TCP particles. Int J Pharm. 2016;511:79-89 pubmed publisher
  4. Pignatelli I, Kumar A, Shah K, Balonis M, Bauchy M, Wu B, et al. Vertical scanning interferometry: A new method to quantify re-/de-mineralization dynamics of dental enamel. Dent Mater. 2016;32:e251-e261 pubmed publisher
    ..Taken together, the outcomes offer new insights that can inform clinicians and researchers on the selection of remineralization strategies. ..